Hennessy Advisors Inc. cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 1.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 81,400 shares of the biopharmaceutical company’s stock after selling 1,600 shares during the quarter. Hennessy Advisors […]